A detailed history of Rothschild Investment LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 50 shares of ARVN stock, worth $1,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 15 233.33%
Holding current value
$1,336
Previous $399,000 208.77%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$23.66 - $32.73 $828 - $1,145
35 Added 233.33%
50 $1.23 Million
Q2 2024

Jul 30, 2024

BUY
$24.46 - $40.4 $366 - $606
15 New
15 $399,000
Q1 2024

Jul 31, 2024

SELL
$36.38 - $52.31 $363 - $523
-10 Reduced 66.67%
5 $206,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.42B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.